Latest filing published 04 Dec 2025 for Biomea Fusion, Inc., €85k.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael J.M. Hitchcock is a declared insider of Biomea Fusion, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 14 November 2022 to 2 December 2025.
The open-market record is one-sided, with 3 purchases worth €214k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 1 purchase and no sales on the market.
Half of the purchases are above €85k and half below. Of 3 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 3 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +12.3%. Past outcomes like these are no guarantee of what comes next.
Most recently, on 4 December 2025, the filings show an open-market purchase worth €85k in Biomea Fusion, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations